15
Apr

The newly downsized Texas-based Lexicon Pharmaceuticals says it nailed promising data on its experimental diabetes drug, positioning it for a late-stage study that could leave it poised to compete with a full lineup of rival treatments already brought to the market by a group of pharma giants.

…read more

Source: Little Lexicon posts positive diabetes data as rival pharma giants race ahead

    

0 No comments